VWA
ABBV icon

Visionary Wealth Advisors’s AbbVie ABBV Stock Holding History

Visionary Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15M Buy
59,531
+2,257
+4% +$486K 0.59% 37
2026
Q1 		$12.5M Buy
57,274
+1,250
+2% +$277K 0.55% 47
2025
Q4 		$12.8M Sell
56,024
-1,244
-2% -$283K 0.58% 40
2025
Q3 		$13.3M Buy
57,268
+60
+0.1% +$12.2K 0.62% 38
2025
Q2 		$10.6M Buy
57,208
+2,029
+4% +$377K 0.54% 44
2025
Q1 		$11.6M Sell
55,179
-2,543
-4% -$494K 0.69% 34
2024
Q4 		$10.3M Buy
57,722
+1,196
+2% +$220K 0.6% 44
2024
Q3 		$11.2M Sell
56,526
-457
-0.8% -$85.3K 0.68% 34
2024
Q2 		$9.77M Buy
56,983
+2,054
+4% +$340K 0.64% 36
2024
Q1 		$10M Sell
54,929
-5,134
-9% -$885K 0.68% 36
2023
Q4 		$9.31M Buy
60,063
+38
+0.1% +$5.54K 0.68% 32
2023
Q3 		$8.95M Buy
60,025
+2,840
+5% +$417K 0.72% 30
2023
Q2 		$7.7M Buy
57,185
+821
+1% +$120K 0.62% 38
2023
Q1 		$8.98M Buy
56,364
+1,401
+3% +$214K 0.76% 31
2022
Q4 		$8.88M Buy
54,963
+1,677
+3% +$257K 0.82% 29
2022
Q3 		$7.15M Buy
53,286
+376
+0.7% +$54K 0.74% 33
2022
Q2 		$8.1M Buy
52,910
+2,308
+5% +$353K 0.73% 34
2022
Q1 		$8.2M Buy
50,602
+1,316
+3% +$191K 0.66% 37
2021
Q4 		$6.67M Buy
49,286
+1,389
+3% +$164K 0.55% 44
2021
Q3 		$5.17M Buy
47,897
+593
+1% +$67.8K 0.53% 47
2021
Q2 		$5.33M Buy
47,304
+141
+0.3% +$15.9K 0.54% 44
2021
Q1 		$5.1M Sell
47,163
-6
-0% -$642 0.54% 47
2020
Q4 		$5.05M Buy
47,169
+2,062
+5% +$198K 0.57% 45
2020
Q3 		$3.95M Buy
45,107
+1,592
+4% +$150K 0.56% 49
2020
Q2 		$4.27M Buy
43,515
+1,859
+4% +$164K 0.65% 39
2020
Q1 		$3.17M Buy
41,656
+2,632
+7% +$224K 0.6% 53
2019
Q4 		$3.46M Buy
+39,024
New +$3.24M 0.62% 47

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Visionary Wealth Advisors's ABBV Position: Q2 2026 in Review

Visionary Wealth Advisors increased its AbbVie (ABBV) stake by 3.9% in Q2 2026, buying an estimated $486K and bringing the position to 59,531 shares worth $15M. The position accounts for 0.59% of the portfolio, ranked #37.

Visionary Wealth Advisors first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Visionary Wealth Advisors held 59,531 shares of AbbVie worth $15M as of Q2 2026.
  • Visionary Wealth Advisors bought 2,257 AbbVie shares in Q2 2026, an estimated $486K.
  • AbbVie made up 0.59% of Visionary Wealth Advisors's portfolio in Q2 2026, its #37 holding.
  • Visionary Wealth Advisors first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Visionary Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.